Agilent Technologies (NYSE:A) Updates FY 2024 Earnings Guidance

Agilent Technologies (NYSE:A) updated its FY 2024 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 5.210-5.250 for the period, compared to the consensus estimate of 5.200. The company issued revenue guidance of $6.5 billion-$6.5 billion, compared to the consensus revenue estimate of $6.5 billion. Agilent Technologies also updated its Q4 guidance to $1.38-1.42 EPS.

Wall Street Analysts Forecast Growth

A has been the topic of a number of analyst reports. TD Cowen restated a buy rating and set a $153.00 target price on shares of Agilent Technologies in a research note on Monday, July 29th. Barclays cut their target price on Agilent Technologies from $135.00 to $125.00 and set an underweight rating for the company in a research report on Friday, May 31st. Citigroup raised Agilent Technologies from a neutral rating to a buy rating and lifted their target price for the company from $135.00 to $150.00 in a research note on Wednesday, July 10th. Evercore ISI boosted their price target on shares of Agilent Technologies from $126.00 to $130.00 and gave the stock an in-line rating in a research note on Tuesday, July 2nd. Finally, UBS Group decreased their target price on Agilent Technologies from $155.00 to $141.00 and set a neutral rating on the stock in a research report on Thursday, May 30th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and nine have given a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of Moderate Buy and a consensus target price of $137.27.

Agilent Technologies Trading Up 0.2 %

Shares of A traded up $0.24 during midday trading on Wednesday, hitting $139.99. The stock had a trading volume of 2,223,862 shares, compared to its average volume of 1,752,576. Agilent Technologies has a 1 year low of $96.80 and a 1 year high of $155.35. The company has a debt-to-equity ratio of 0.34, a current ratio of 2.15 and a quick ratio of 1.64. The stock’s 50 day moving average is $133.62 and its 200 day moving average is $138.47. The firm has a market cap of $40.84 billion, a PE ratio of 33.21, a price-to-earnings-growth ratio of 4.86 and a beta of 1.05.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, May 29th. The medical research company reported $1.22 earnings per share for the quarter, topping analysts’ consensus estimates of $1.19 by $0.03. Agilent Technologies had a net margin of 18.84% and a return on equity of 26.25%. The company had revenue of $1.57 billion for the quarter, compared to analyst estimates of $1.58 billion. During the same period in the prior year, the company posted $1.27 EPS. The firm’s revenue for the quarter was down 8.4% on a year-over-year basis. As a group, analysts forecast that Agilent Technologies will post 5.24 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, CEO Padraig Mcdonnell sold 1,958 shares of Agilent Technologies stock in a transaction dated Friday, July 26th. The shares were sold at an average price of $140.00, for a total transaction of $274,120.00. Following the completion of the sale, the chief executive officer now owns 26,076 shares in the company, valued at approximately $3,650,640. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other Agilent Technologies news, SVP Dominique Grau sold 15,000 shares of the firm’s stock in a transaction on Monday, June 10th. The stock was sold at an average price of $133.28, for a total transaction of $1,999,200.00. Following the transaction, the senior vice president now directly owns 49,486 shares in the company, valued at approximately $6,595,494.08. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Padraig Mcdonnell sold 1,958 shares of the company’s stock in a transaction on Friday, July 26th. The stock was sold at an average price of $140.00, for a total value of $274,120.00. Following the completion of the sale, the chief executive officer now owns 26,076 shares of the company’s stock, valued at $3,650,640. The disclosure for this sale can be found here. Insiders have sold a total of 18,916 shares of company stock worth $2,527,860 over the last quarter. Company insiders own 0.33% of the company’s stock.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.